SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-21-041618
Filing Date
2021-02-12
Accepted
2021-02-12 16:24:52
Documents
2
Group Members
ANSBERT GADICKEED HURWITZLUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV2018 LLCMPM BIOVENTURES 2018 (B), L.P.MPM BIOVENTURES 2018 GP LLCMPM BIOVENTURES 2018 LLCTODD FOLEY

Document Format Files

Seq Description Document Type Size
1 SC 13G d63556dsc13g.htm SC 13G 159610
2 EX-99.A d63556dex99a.htm EX-99.A 15486
  Complete submission text file 0001193125-21-041618.txt   176818
Mailing Address 450 KENDALL STREET CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET CAMBRIDGE MA 02142 617-425-9200
MPM BIOVENTURES 2018, L.P. (Filed by) CIK: 0001729505 (see all company filings)

IRS No.: 823687697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Subject) CIK: 0001818794 (see all company filings)

IRS No.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91706 | Film No.: 21627952
SIC: 2834 Pharmaceutical Preparations